Irina V. Leontyeva

Irina V. Leontyeva

Auto-generated profile, based on publicly available information

Irina V. Leontyeva

Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2020 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Open access
PDF file
ILI. V. Leontyeva
I. V. Leontyeva
Современная стратегия диагностики и лечения семейной гетерозиготной гиперхолестеринемии у детей

9 March 2019 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Open access
PDF file
ILI. V. Leontyeva
I. V. Leontyeva
Лечение артериальной гипертензии у детей и подростков

10 October 2023 in Eurasian heart journal
Verified
Journal Article
Open access
PDF file
OKO. A. Kislyak
O. A. Kislyak
ILI. V. Leontyeva
I. V. Leontyeva
ASAntonina Vladimirovna Starodubova
Antonina Vladimirovna Starodubova
AAA. A. Alersandrov
A. A. Alersandrov
MBMarina G. Bubnova
Marina G. Bubnova
SUS. A. Ushakova
S. A. Ushakova
The EAC Guidelines represent the views of the EAC, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication.

1 January 2021 in Clinical and Experimental Surgery. Petrovsky journal
Verified
Journal Article
Closed access
SDS.L. Dzemeshkevich
S.L. Dzemeshkevich
PSPetrovsky National Research Center of Surgery
Petrovsky National Research Center of Surgery
AMA.P. Motreva
A.P. Motreva
EKE.P. Kalachanova
E.P. Kalachanova
TNT.G. Nikityuk
T.G. Nikityuk
FSFederal Center For Cardiovascular Surgery
Federal Center For Cardiovascular Surgery

29 September 2021 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Open access
PDF file
ILI. V. Leontyeva
I. V. Leontyeva
Familial homozygous hypercholesterolemia is a rare life-threatening disease, the prevalence is 1: 160,000-1: 320,000. The main manifestation of the disease is an extremely high level of low-density lipoprotein cholesterol (more than 13 mmol / l), which causes early atherosclerotic vascular lesions, including coronary arteries, starting from the first decade of life, and can lead to myocardial infarction in childhood. Familial homozygous hypercholesterolemia remains a little-known disease in the clinical practice of the pediatrician; it leads to delayed diagnosis and late initiation of therapy. The most common cause of the disease is mutations in the LDLR (90%) gene, less often in the APOB (5–10%), PCSK9 (1%), LDLRAP1 (1%) genes. The article presents the criteria for the diagnosis of familial homozygous hypercholesterolemia in children. The authors discuss clinical manifestations on the skin and at the level of the cardiovascular system, eyes. They present the strategy of management and the possibilities of treating patients. The paper presents the indications for the appointment and the effectiveness of statins, ezetrol, monoclonal antibodies to PCSK9, apheresis for the treatment of the disease. It discusses prospects for further therapy.

6 June 2021 in Osteoporosis and Bone Diseases
Verified
Journal Article
Open access
PDF file
EDEkaterina N. Dudinskaya
Ekaterina N. Dudinskaya
ОТОльга Николаевна Ткачева
Ольга Николаевна Ткачева
LMLyubov V. Machekhina
Lyubov V. Machekhina
KEK. Eruslanova
K. Eruslanova
ИКИгорь Александрович Ковалев
Игорь Александрович Ковалев
ЛМЛюбовь Викторовна Мачехина
Любовь Викторовна Мачехина
Background: Osteoporosis and cardiovascular disease (CVD) are among the most common causes of morbidity, disability and death worldwide. In recent years, more and more data have been accumulating on the presence of an age-independent relationship and general pathogenetic mechanisms of a decrease in bone mineral density (BMD) and the development of CVD. It has been shown that a decrease in BMD is an important independent predictor of the risk of atherosclerosis of the great arteries and is associated with increased calcification of the aorta and other vessels. The strongest relationship between these parameters was observed in the study of the female population, in connection with which we selected a group of middle-aged women for analysis.Objective: to investigate the association between bone mineral density and carotid intima-media thickness in middle-aged women.Results: 35 women were included in the study. The mean age was 44,74±4,32 years. We found the following changes in arterial wall characteristics: atherosclerosis — 21,9% women, increased carotid intima thickness — 15,7% women. Low bone mineral density for chronological age (Z-criteria -2,0 and less) was found in 7 patients at the age of 35±2,7 years. We discovered a negative correlation between the markers of subclinical atherosclerosis and bone mass: Ccarotid intimamedia thickness negatively correlated with bone mineral density in hip (p<0,05), and presence of atherosclerosis plaques was associated with lower bone mineral density in the proximal part of hip (p<0,05).Conclusion: The findings about negative association between bone mineral density of hip with preclinical markers of atherosclerosis allow us to make a conclusion about their interaction.